Alexandre Prieur

PhD in oncology (University of Paris)

12 years of fundamental research as a researcher at prestigious cancer research institutes in Europe (Institut Curie and Netherlands Cancer institute).

12 years of R&D specific to circulating progastrin (hPG80) as Chief Scientific Officer (diagnostics and therapy).

Listed as inventor of 10 patent applications, including 9 on the interaction between hPG80 and cancer.

Author of over 15 publications in peer-reviewed journals in the field of cancer, including 8 on the interaction between hPG80 and cancer.